{"id":100672,"date":"2006-10-17T08:50:16","date_gmt":"2006-10-17T05:50:16","guid":{"rendered":"https:\/\/www.17047165566933.sritis.lt\/index.php\/2006\/10\/17\/kruties-veziu-serganciu-moteru-viltis-gyventi-valdininku-rankose\/"},"modified":"2006-10-17T08:50:16","modified_gmt":"2006-10-17T05:50:16","slug":"kruties-veziu-serganciu-moteru-viltis-gyventi-valdininku-rankose","status":"publish","type":"post","link":"https:\/\/www.santaka.info\/index.php\/2006\/10\/17\/kruties-veziu-serganciu-moteru-viltis-gyventi-valdininku-rankose\/","title":{"rendered":"Kr\u016bties v\u0117\u017eiu sergan\u010di\u0173 moter\u0173 viltis gyventi \u2013 valdinink\u0173 rankose"},"content":{"rendered":"<p><em><\/em><\/p>\n<p><b>Pasira\u0161ykite peticij\u0105<\/b><br \/>\n<br \/>\u201eKasmet Lietuvoje tik 50 agresyvia HER2 teigiamo kr\u016bties v\u0117\u017eio forma sergan\u010di\u0173 moter\u0173 gali d\u017eiaugtis galimybe gauti gyvyb\u0119 i\u0161saugan\u010di\u0105 biologin\u0119 terapij\u0105. Padovanokime gyvenim\u0105 dar 250 \u0161alies moter\u0173, laukian\u010di\u0173 savo \u0161anso \u012f gyvyb\u0119\u201c.<br \/>\n<br \/>Tai nedidel\u0117 i\u0161trauka i\u0161 peticijos, kurioje kr\u016bties v\u0117\u017eiu sergan\u010dios moterys ragina vald\u017eios institucijas rasti l\u0117\u0161\u0173 biologin\u0117s terapijos medikamentams kompensuoti.<br \/>\n<br \/>Taip pat peticijoje pra\u0161oma per\u017ei\u016br\u0117ti onkologijos srities finansavim\u0105, reformavim\u0105, prapl\u0117sti ir modernizuoti, apr\u016bpinant naujausia diagnostine bei gydymo technika, onkologines \u012fstaigas Vilniuje, Kaune, Klaip\u0117doje, \u0160iauliuose, Panev\u0117\u017eyje, pailginti onkologini\u0173 lig\u0173 diagnostikos kabinet\u0173 darbo laik\u0105 ir padidinti \u010dia dirban\u010di\u0173 specialist\u0173 kiek\u012f.<br \/>\n<br \/>Spalio m\u0117nes\u012f vykstan\u010dios socialin\u0117s akcijos metu peticij\u0105, kurios tekst\u0105 galima rasti internetin\u0117je svetain\u0117je www.roziniskaspinas.lt, pasira\u0161yti kvie\u010diama visa visuomen\u0117, taip i\u0161rei\u0161kiant param\u0105 kovai su kr\u016bties v\u0117\u017eiu.<br \/>\n<br \/>Pra\u0117jus daugiau nei savaitei nuo akcijos prad\u017eios, jau yra surinkta per 30 t\u016bkstan\u010di\u0173 para\u0161\u0173 ir kiekvien\u0105 dien\u0105 j\u0173 skai\u010dius tik auga. Tai parodo, jog Lietuvos gyventojai yra geranori\u0161ki ir neabejingi \u0161iai socialinei akcijai.<br \/>\n<br \/>Lapkri\u010dio prad\u017eioje peticija su para\u0161ais bus perduota \u0161alies Prezidentui Valdui Adamkui, Ministrui Pirmininkui Gediminui Kirkilui ir sveikatos apsaugos ministrui Rimvydui Tur\u010dinskui.<\/p>\n<p><b>Vaistai prieinami ne<br \/>\nvisoms ligon\u0117ms<\/b><br \/>\n<br \/>Sergamumas onkologin\u0117mis ligomis Lietuvoje spar\u010diai auga \u2013 vien pernai u\u017eregistruota per 16 t\u016bkst. nauj\u0173 v\u0117\u017eio susirgim\u0173, o kr\u016bties v\u0117\u017eiu per metus suserga apie 1300 moter\u0173. Tuo tarpu nepriklausom\u0173 ekspert\u0173, bendrov\u0117s \u201eHealth Consumer Powerhouse\u201c ataskaitos i\u0161vadose teigiama, kad Lietuvoje onkologin\u0117 pagalba ligoniams smarkiai atsilieka nuo kit\u0173 ES \u0161ali\u0173.<br \/>\n<br \/>Pasak Europos kovos su kr\u016bties v\u0117\u017eiu koalicijos \u201eEuropa Donna\u201c atstov\u0117s Lietuvoje ir Nacionalin\u0117s moter\u0173, sergan\u010di\u0173 kr\u016bties ligomis, organizacij\u0173 asociacijos viceprezident\u0117s Erikos Umbrasait\u0117s, kr\u016bties v\u0117\u017eiu moterys suserga nepaisant nei j\u0173 am\u017eiaus, nei visuomeninio statuso. Nors efektyv\u016bs gydymo b\u016bdai, galintys i\u0161gelb\u0117ti \u0161imtus moter\u0173 gyvybi\u0173, jau sukurti, ta\u010diau d\u0117l didel\u0117s kainos daugumai ligoni\u0173 jie tiesiog neprieinami.<br \/>\n<br \/>HER2 teigiamu kr\u016bties v\u0117\u017eiu da\u017eniausiai suserga jaunos moterys iki 45 met\u0173 am\u017eiaus.<br \/>\n<br \/>Tai klastinga ir agresyvi ligos forma, nes standartiniai kr\u016bties v\u0117\u017eiui gydyti skirti chemoterapiniai vaistai n\u0117ra pakankamai efektyv\u016bs, tod\u0117l liga grei\u010diau progresuoja, v\u0117\u017eys greitai i\u0161plinta \u012f kitus organus.<br \/>\n<br \/>Naudojant biologin\u0119 terapij\u0105, lig\u0105 galima visai sustabdyti arba prailginti kokybi\u0161k\u0105 gyvenim\u0105 beveik pusei agresyvia HER2 teigiamo kr\u016bties v\u0117\u017eio forma susirgusi\u0173 moter\u0173.<br \/>\n<br \/>Biologin\u0117s terapijos medikamentas \u201eHerceptinas\u201c \u0161iuo metu yra vienintelis vaistas, galintis i\u0161gelb\u0117ti \u0161i\u0173 moter\u0173 gyvybes.<br \/>\n<br \/>\u0160is vaistas tinka tiek ankstyvo, tiek pa\u017eengusio HER2 teigiamo kr\u016bties v\u0117\u017eio gydymui.<br \/>\n<br \/>\u201eS\u0105\u017einingai vis\u0105 gyvenim\u0105 mokes\u010dius valstybei mok\u0117jusios Lietuvos moterys nori b\u016bti gydomos tokiais pat vaistais, kaip ir daugelyje ES \u0161ali\u0173. Modernus gydymas turi b\u016bti prieinamas visoms, nepaisant socialinio sluoksnio ar finansin\u0117s pad\u0117ties\u201c, \u2013 pa\u017eym\u0117jo E.Umbrasait\u0117.<\/p>\n<p><b>K\u0105 reikia \u017einoti, kovojant su kr\u016bties v\u0117\u017eiu<\/b><br \/>\n<br \/>Da\u017eniausiai pasitaikanti v\u0117\u017eio forma \u2013 kr\u016bties v\u0117\u017eys.<br \/>\n<br \/>Buvo nustatyta, kad pasaulyje apytiksliai viena i\u0161 8\u201310 moter\u0173 suserga kr\u016bties v\u0117\u017eiu. Da\u017eniausiai juo serga 55\u201365 met\u0173 moterys, nors paskutiniu metu pastebima g\u0105sdinanti tendencija, kuomet kr\u016bties v\u0117\u017eys renkasi vis jaunesnes aukas.<br \/>\n<br \/>Apie 70 proc. vis\u0173 kr\u016bties v\u0117\u017eio atvej\u0173 pirmiausia atranda pa\u010dios moterys arba j\u0173 partneriai.<br \/>\n<br \/>Dauguma kr\u016btyje randam\u0173 augli\u0173 yra nepiktybiniai. Ma\u017edaug trys i\u0161 keturi\u0173 gumbeli\u0173 (75 proc.), kurie i\u0161 prad\u017ei\u0173 buvo diagnozuoti kaip piktybiniai kr\u016bties v\u0117\u017eio augliai, po v\u0117lesni\u0173 tyrim\u0173 pasirod\u0117 es\u0105 gerybiniai: cistos, fibroadenomos arba lipomos, kurios yra nesunkiai nustatomos ir gydomos.<br \/>\n<br \/>I\u0161samesni tyrimai atliekami tik tuomet, kai po pirmin\u0117s ap\u017ei\u016bros kyla \u012ftarim\u0173 d\u0117l v\u0117\u017eio. Ta\u010diau svarbiausia, aptikus kr\u016btyje kok\u012f nors ne\u012fprast\u0105 darin\u012f arba gumbel\u012f, nepanikuoti ir kuo skubiausiai kreiptis \u012f gydytoj\u0105.<\/p>\n<p>Saulius JANSONAS<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pasira\u0161ykite peticij\u0105 \u201eKasmet Lietuvoje tik 50 agresyvia HER2 teigiamo kr\u016bties v\u0117\u017eio forma sergan\u010di\u0173 moter\u0173 gali d\u017eiaugtis galimybe gauti gyvyb\u0119 i\u0161saugan\u010di\u0105 biologin\u0119 terapij\u0105. Padovanokime gyvenim\u0105 dar 250 \u0161alies moter\u0173, laukian\u010di\u0173 savo&#8230; <\/p>\n","protected":false},"author":1,"featured_media":100673,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pmpro_default_level":"","jetpack_post_was_ever_published":false,"_FSMCFIC_featured_image_caption":"Austral\u0173 popmuzikos super\u017evaig\u017edei Kylie Minogue s\u0117kmingai kovoti su kr\u016bties v\u0117\u017eiu pad\u0117jo artim\u0173j\u0173 palaikymas ir tik\u0117jimas savimi. \/ ","_FSMCFIC_featured_image_nocaption":"","_FSMCFIC_featured_image_hide":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-100672","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","pmpro-has-access"],"featured_image_urls":{"full":["https:\/\/www.santaka.info\/wp-content\/uploads\/2025\/01\/20061017085016.jpg",420,336,false],"thumbnail":["https:\/\/www.santaka.info\/wp-content\/uploads\/2025\/01\/20061017085016-150x150.jpg",150,150,true],"medium":["https:\/\/www.santaka.info\/wp-content\/uploads\/2025\/01\/20061017085016-300x240.jpg",300,240,true],"medium_large":["https:\/\/www.santaka.info\/wp-content\/uploads\/2025\/01\/20061017085016.jpg",420,336,false],"large":["https:\/\/www.santaka.info\/wp-content\/uploads\/2025\/01\/20061017085016.jpg",420,336,false],"1536x1536":["https:\/\/www.santaka.info\/wp-content\/uploads\/2025\/01\/20061017085016.jpg",420,336,false],"2048x2048":["https:\/\/www.santaka.info\/wp-content\/uploads\/2025\/01\/20061017085016.jpg",420,336,false],"post-thumbnail":["https:\/\/www.santaka.info\/wp-content\/uploads\/2025\/01\/20061017085016.jpg",420,336,false],"visualnews_post_thumb":["https:\/\/www.santaka.info\/wp-content\/uploads\/2025\/01\/20061017085016.jpg",420,336,false],"woocommerce_thumbnail":["https:\/\/www.santaka.info\/wp-content\/uploads\/2025\/01\/20061017085016-300x300.jpg",300,300,true],"woocommerce_single":["https:\/\/www.santaka.info\/wp-content\/uploads\/2025\/01\/20061017085016.jpg",420,336,false],"woocommerce_gallery_thumbnail":["https:\/\/www.santaka.info\/wp-content\/uploads\/2025\/01\/20061017085016-100x100.jpg",100,100,true]},"author_info":{"info":["admin"]},"category_info":"<a href=\"https:\/\/www.santaka.info\/index.php\/category\/uncategorized\/\" rel=\"category tag\">Be kategorijos<\/a>","tag_info":"Be kategorijos","comment_count":"0","jetpack_featured_media_url":"https:\/\/www.santaka.info\/wp-content\/uploads\/2025\/01\/20061017085016.jpg","jetpack_sharing_enabled":true,"jetpack-related-posts":[],"_links":{"self":[{"href":"https:\/\/www.santaka.info\/index.php\/wp-json\/wp\/v2\/posts\/100672","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.santaka.info\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.santaka.info\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.santaka.info\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.santaka.info\/index.php\/wp-json\/wp\/v2\/comments?post=100672"}],"version-history":[{"count":0,"href":"https:\/\/www.santaka.info\/index.php\/wp-json\/wp\/v2\/posts\/100672\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.santaka.info\/index.php\/wp-json\/wp\/v2\/media\/100673"}],"wp:attachment":[{"href":"https:\/\/www.santaka.info\/index.php\/wp-json\/wp\/v2\/media?parent=100672"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.santaka.info\/index.php\/wp-json\/wp\/v2\/categories?post=100672"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.santaka.info\/index.php\/wp-json\/wp\/v2\/tags?post=100672"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}